Advertisement Taj Pharma receives FDA approval to manufacture Papaverine - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Taj Pharma receives FDA approval to manufacture Papaverine

Taj Pharmaceuticals of India has received tentative approval from the US FDA to manufacture and sell Drug Papaverine capsules 150 mg to market in European Market.

Papaverine, an opium alkaloid is used to treat visceral spasm, vasospasm, and erectile dysfunction, besides being used as a smooth muscle relaxant in microsurgery.

The FDA held Papaverine in its priority review for new molecular entity (NME) for more than 3 years.

Taj Pharmaceuticals makes pharmaceutical formulations and API for India and other countries.